PHR
Get informed when a big investor buys or sells
+ FollowUndervalued by 169.3% based on the discounted cash flow analysis.
| Market cap | $668.19 Million |
|---|---|
| Enterprise Value | $696.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | 0.84 |
| Outstanding Shares | 61,878,316 |
| P/E Ratio | 62.78 |
|---|---|
| PEG | 10.51 |
| Price to Sales | 1.38 |
| Price to Book Ratio | 1.84 |
| Enterprise Value to Revenue | 1.37 |
| Enterprise Value to EBIT | 82.79 |
| Enterprise Value to Net Income | -119 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.27 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 29.16% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 95.05% |
|---|---|
| Total Invested | $66,030▼ 99.99% |
| Investors Holding | 4▼ 233.00% |
No data
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...